Page last updated: 2024-12-11

monorden

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

monorden: inhibits HSP90 Heat-Shock Proteins, DNA topoisomerase VI and human Topoisomerase II [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6323491
CHEMBL ID414883
CHEBI ID556075
SCHEMBL ID868832
MeSH IDM0108420

Synonyms (48)

Synonym
monorden
RDC ,
nsc 294404
monorderne
6h-oxireno(e)(2)benzoxacyclotetradecin-6,12(7h)-dione, 8-chloro-1a,14,15,15a-tetrahydro-9,11-dihydroxy-14-methyl-
rhi-12648
nsc-294404
RDI ,
radicicol from diheterospora chlamydosporia, solid
DB03758
1BGQ
(4r,6r,8r,9z,11e)-16-chloro-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0;{6,8}]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione
chembl414883 ,
bdbm15361
microlactone, 1
(1ar,2z,4e,14r,15ar)-8-chloro-9,11-dihydroxy-14-methyl-1a,14,15,15a-tetrahydro-6h-oxireno[e][2]benzoxacyclotetradecine-6,12(7h)-dione
3CGY
2ZBK
2Q8I
CHEBI:556075 ,
(+)-monorden a
radicicol r 2146
radisicol
radicolol
i60eh8gecx ,
monorden a
unii-i60eh8gecx
radicicol from diheterospora chlamydosporia
4EGK
SCHEMBL868832
CCG-208260
2WER
.beta.-resorcylic acid, 5-chloro-6-(7,8-epoxy-10-hydroxy-2-oxo-3,5-undecadienyl)-, .mu.-lactone
radicicol r-2146
monorden [mi]
AKOS024456686
HMS3648C16
mfcd06795865
5-cl-6-(7,8-epoxy-10-hydroxy-2-oxo-3,5-undecadienyl)-beta-resorcylic acid mu-lactone
NCGC00344093-09
radicicol, diheterospora chlamydosporia - cas 12772-57-5
SR-01000946352-1
sr-01000946352
bdbm227589
CS-0028899
HY-N6769
NCGC00344093-06
BR162744

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Some of these compounds exhibit low nanomolar inhibition activity in a Her-2 degradation assay (28-150 nM), good aqueous solubility, and oral bioavailability profiles in mice."( 7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors.
Biamonte, M; Boehm, MF; Burrows, FJ; Busch, DJ; Fan, J; Grecko, R; Hong, K; Kamal, A; Kasibhatla, SR; Le Brazidec, JY; Lough, RE; Lundgren, K; Mansfield, R; Ran, Y; Sensintaffar, JL; Shi, J; Timony, GA; Ulm, EH; Vu, K; Zhang, L, 2006
)
0.33
"A decline in the bioavailability of nitric oxide (NO) that causes endothelial dysfunction is a hallmark of diabetes."( High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction.
Centonze, VE; Konopinski, R; Mohan, S; Natarajan, M; Yan, B, 2009
)
0.35
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
tyrosine kinase inhibitorAny protein kinase inhibitor that interferes with the action of tyrosine kinase.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
macrolide antibioticA macrocyclic lactone with a ring of twelve or more members which exhibits antibiotic activity.
epoxideAny cyclic ether in which the oxygen atom forms part of a 3-membered ring.
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
cyclic ketone
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
monochlorobenzenesAny member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (22)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1Homo sapiens (human)IC50 (µMol)400.00000.0870200.0435400.0000AID977608
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3Homo sapiens (human)IC50 (µMol)400.00000.0870200.0435400.0000AID977608
ATP-dependent molecular chaperone HSP82Saccharomyces cerevisiae S288CIC50 (µMol)0.11930.03004.38148.9000AID1797382; AID1799517; AID1799518
Heat shock protein HSP 90-alphaHomo sapiens (human)IC50 (µMol)0.20920.00040.695010.0000AID242027; AID257070; AID32535; AID604443; AID604444
Heat shock protein HSP 90-alphaHomo sapiens (human)Ki20.00000.00020.54152.7000AID1441284
Heat shock protein HSP 90-betaHomo sapiens (human)IC50 (µMol)0.11480.00100.683610.0000AID1073049; AID1797381; AID1797384; AID257070; AID32535; AID395896
Heat shock protein HSP 90-betaHomo sapiens (human)Ki20.00000.00010.03730.5300AID1441284
ATP-dependent molecular chaperone HSC82Saccharomyces cerevisiae S288CIC50 (µMol)0.20000.14002.01335.7000AID242325
Carbonyl reductase [NADPH] 1Homo sapiens (human)IC50 (µMol)3.27000.40002.03003.7800AID347259
Carbonyl reductase [NADPH] 1Homo sapiens (human)Ki0.52000.06001.12503.4300AID347259
ATP-citrate synthase Rattus norvegicus (Norway rat)Ki10.00000.15004.75718.0000AID1408671; AID1408672; AID697049; AID697050
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)0.02700.00010.995010.0000AID403340
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)IC50 (µMol)235.93330.00051.89099.5000AID1170874; AID1441285; AID1802790
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)IC50 (µMol)77.80000.06503.12999.5000AID1802790
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)IC50 (µMol)153.90000.02603.56669.5000AID1170875; AID1802790
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)IC50 (µMol)77.80000.02103.58609.5000AID1802790
Proto-oncogene tyrosine-protein kinase Src Rattus norvegicus (Norway rat)IC50 (µMol)0.18000.18000.18000.1800AID228843
Histidine kinase Caulobacter vibrioidesIC50 (µMol)184.00007.30007.30007.3000AID1372065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HEAT SHOCK PROTEIN 90Saccharomyces cerevisiae (brewer's yeast)Kd0.00270.00270.00270.0027AID977611
Chain A, Atp-dependent Molecular Chaperone Hsp82Saccharomyces cerevisiae (brewer's yeast)Kd0.09000.09000.09000.0900AID977611
Chain A, Atp-dependent Molecular Chaperone Hsp82Saccharomyces cerevisiae (brewer's yeast)Kd0.09000.09000.09000.0900AID977611
Chain B, Type 2 DNA topoisomerase 6 subunit BSaccharolobus shibataeKd2.00002.00002.00002.0000AID977611
Chain A, Virulence sensor histidine kinase phoQSalmonella enterica subsp. enterica serovar TyphimuriumKd715.0000715.0000715.0000715.0000AID977611
ATP-dependent molecular chaperone HSP82Saccharomyces cerevisiae S288CKd0.01900.01900.60951.2000AID395890
Heat shock protein HSP 90-alphaHomo sapiens (human)EC50 (µMol)0.02500.00400.13311.2000AID269704
Heat shock protein HSP 90-alphaHomo sapiens (human)Kd4.14380.00030.94889.8000AID1604457; AID1625193; AID1761924; AID1802791; AID730648; AID87631; AID87632
Heat shock protein HSP 90-betaHomo sapiens (human)EC50 (µMol)0.02500.00400.23851.7000AID269704
Heat shock protein HSP 90-betaHomo sapiens (human)Kd0.01060.00031.33309.8000AID1604457; AID763529
Histamine H1 receptorRattus norvegicus (Norway rat)Kd0.00270.00270.00270.0027AID87631
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)Kd12.41540.04630.04630.0463AID1802791
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Heat shock protein HSP 90-betaHomo sapiens (human)ED500.04500.04500.10250.1600AID395896
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (140)

Processvia Protein(s)Taxonomy
telomere maintenance via telomeraseHeat shock protein HSP 90-alphaHomo sapiens (human)
neuron migrationHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of protein phosphorylationHeat shock protein HSP 90-alphaHomo sapiens (human)
activation of innate immune responseHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of defense response to virus by hostHeat shock protein HSP 90-alphaHomo sapiens (human)
skeletal muscle contractionHeat shock protein HSP 90-alphaHomo sapiens (human)
mitochondrial transportHeat shock protein HSP 90-alphaHomo sapiens (human)
response to unfolded proteinHeat shock protein HSP 90-alphaHomo sapiens (human)
response to heatHeat shock protein HSP 90-alphaHomo sapiens (human)
response to coldHeat shock protein HSP 90-alphaHomo sapiens (human)
response to xenobiotic stimulusHeat shock protein HSP 90-alphaHomo sapiens (human)
response to salt stressHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of lamellipodium assemblyHeat shock protein HSP 90-alphaHomo sapiens (human)
cardiac muscle cell apoptotic processHeat shock protein HSP 90-alphaHomo sapiens (human)
regulation of protein ubiquitinationHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of protein polymerizationHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of interferon-beta productionHeat shock protein HSP 90-alphaHomo sapiens (human)
regulation of protein localizationHeat shock protein HSP 90-alphaHomo sapiens (human)
protein refoldingHeat shock protein HSP 90-alphaHomo sapiens (human)
response to cocaineHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of protein import into nucleusHeat shock protein HSP 90-alphaHomo sapiens (human)
regulation of apoptotic processHeat shock protein HSP 90-alphaHomo sapiens (human)
regulation of protein-containing complex assemblyHeat shock protein HSP 90-alphaHomo sapiens (human)
protein unfoldingHeat shock protein HSP 90-alphaHomo sapiens (human)
response to estrogenHeat shock protein HSP 90-alphaHomo sapiens (human)
protein insertion into mitochondrial outer membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of nitric oxide biosynthetic processHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of protein catabolic processHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of cell sizeHeat shock protein HSP 90-alphaHomo sapiens (human)
response to antibioticHeat shock protein HSP 90-alphaHomo sapiens (human)
protein stabilizationHeat shock protein HSP 90-alphaHomo sapiens (human)
chaperone-mediated protein complex assemblyHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of cardiac muscle contractionHeat shock protein HSP 90-alphaHomo sapiens (human)
chaperone-mediated autophagyHeat shock protein HSP 90-alphaHomo sapiens (human)
cellular response to virusHeat shock protein HSP 90-alphaHomo sapiens (human)
regulation of postsynaptic membrane neurotransmitter receptor levelsHeat shock protein HSP 90-alphaHomo sapiens (human)
positive regulation of tau-protein kinase activityHeat shock protein HSP 90-alphaHomo sapiens (human)
telomerase holoenzyme complex assemblyHeat shock protein HSP 90-alphaHomo sapiens (human)
cellular response to heatHeat shock protein HSP 90-alphaHomo sapiens (human)
protein foldingHeat shock protein HSP 90-alphaHomo sapiens (human)
telomere maintenance via telomeraseHeat shock protein HSP 90-betaHomo sapiens (human)
placenta developmentHeat shock protein HSP 90-betaHomo sapiens (human)
response to unfolded proteinHeat shock protein HSP 90-betaHomo sapiens (human)
virion attachment to host cellHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of transforming growth factor beta receptor signaling pathwayHeat shock protein HSP 90-betaHomo sapiens (human)
regulation of protein ubiquitinationHeat shock protein HSP 90-betaHomo sapiens (human)
negative regulation of proteasomal ubiquitin-dependent protein catabolic processHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of phosphoprotein phosphatase activityHeat shock protein HSP 90-betaHomo sapiens (human)
regulation of protein localizationHeat shock protein HSP 90-betaHomo sapiens (human)
negative regulation of apoptotic processHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of nitric oxide biosynthetic processHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of cell differentiationHeat shock protein HSP 90-betaHomo sapiens (human)
chaperone-mediated protein complex assemblyHeat shock protein HSP 90-betaHomo sapiens (human)
regulation of cell cycleHeat shock protein HSP 90-betaHomo sapiens (human)
chaperone-mediated protein foldingHeat shock protein HSP 90-betaHomo sapiens (human)
cellular response to interleukin-4Heat shock protein HSP 90-betaHomo sapiens (human)
supramolecular fiber organizationHeat shock protein HSP 90-betaHomo sapiens (human)
negative regulation of proteasomal protein catabolic processHeat shock protein HSP 90-betaHomo sapiens (human)
telomerase holoenzyme complex assemblyHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of protein localization to cell surfaceHeat shock protein HSP 90-betaHomo sapiens (human)
cellular response to heatHeat shock protein HSP 90-betaHomo sapiens (human)
protein foldingHeat shock protein HSP 90-betaHomo sapiens (human)
protein stabilizationHeat shock protein HSP 90-betaHomo sapiens (human)
xenobiotic metabolic processCarbonyl reductase [NADPH] 1Homo sapiens (human)
glucocorticoid metabolic processCarbonyl reductase [NADPH] 1Homo sapiens (human)
cyclooxygenase pathwayCarbonyl reductase [NADPH] 1Homo sapiens (human)
epithelial cell differentiationCarbonyl reductase [NADPH] 1Homo sapiens (human)
vitamin K metabolic processCarbonyl reductase [NADPH] 1Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCarbonyl reductase [NADPH] 1Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
glucose metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
cell population proliferation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stress[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
regulation of acetyl-CoA biosynthetic process from pyruvate[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
regulation of glucose metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
hypoxia-inducible factor-1alpha signaling pathway[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
protein phosphorylation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
glucose metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of gluconeogenesis[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of pH[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
insulin receptor signaling pathway[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of acetyl-CoA biosynthetic process from pyruvate[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of cellular ketone metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of glucose metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
cellular response to nutrient[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
cellular response to reactive oxygen species[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
glucose homeostasis[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of calcium-mediated signaling[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediator[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
protein phosphorylation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
regulation of acetyl-CoA biosynthetic process from pyruvate[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
regulation of glucose metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
peptidyl-serine phosphorylation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
peroxisome proliferator activated receptor signaling pathway[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
cellular response to fatty acid[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
hypoxia-inducible factor-1alpha signaling pathway[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
regulation of reactive oxygen species metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
protein phosphorylation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
regulation of pH[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
insulin receptor signaling pathway[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
cellular response to starvation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of acetyl-CoA biosynthetic process from pyruvate[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of cellular ketone metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of glucose metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of fatty acid biosynthetic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
glucose homeostasis[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
response to starvation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of bone resorption[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
regulation of fatty acid oxidation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
cellular response to fatty acid[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
reactive oxygen species metabolic process[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
negative regulation of anoikis[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
protein phosphorylation[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (58)

Processvia Protein(s)Taxonomy
UTP bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
CTP bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
RNA bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
mRNA bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
protein bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
ATP bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
GTP bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
ATP hydrolysis activityHeat shock protein HSP 90-alphaHomo sapiens (human)
sulfonylurea receptor bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
protein phosphatase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
MHC class II protein complex bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
nitric-oxide synthase regulator activityHeat shock protein HSP 90-alphaHomo sapiens (human)
TPR domain bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
ubiquitin protein ligase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
dATP bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
identical protein bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
protein homodimerization activityHeat shock protein HSP 90-alphaHomo sapiens (human)
histone deacetylase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
transmembrane transporter bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
tau protein bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
GTPase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
Rho GDP-dissociation inhibitor bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
DNA polymerase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
scaffold protein bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
disordered domain specific bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
ATP-dependent protein folding chaperoneHeat shock protein HSP 90-alphaHomo sapiens (human)
protein tyrosine kinase bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
unfolded protein bindingHeat shock protein HSP 90-alphaHomo sapiens (human)
RNA bindingHeat shock protein HSP 90-betaHomo sapiens (human)
double-stranded RNA bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP hydrolysis activityHeat shock protein HSP 90-betaHomo sapiens (human)
protein kinase regulator activityHeat shock protein HSP 90-betaHomo sapiens (human)
kinase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein kinase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
MHC class II protein complex bindingHeat shock protein HSP 90-betaHomo sapiens (human)
nitric-oxide synthase regulator activityHeat shock protein HSP 90-betaHomo sapiens (human)
TPR domain bindingHeat shock protein HSP 90-betaHomo sapiens (human)
heat shock protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ubiquitin protein ligase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
peptide bindingHeat shock protein HSP 90-betaHomo sapiens (human)
identical protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein homodimerization activityHeat shock protein HSP 90-betaHomo sapiens (human)
histone deacetylase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP-dependent protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein folding chaperoneHeat shock protein HSP 90-betaHomo sapiens (human)
cadherin bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein dimerization activityHeat shock protein HSP 90-betaHomo sapiens (human)
tau protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
DNA polymerase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
disordered domain specific bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP-dependent protein folding chaperoneHeat shock protein HSP 90-betaHomo sapiens (human)
receptor ligand inhibitor activityHeat shock protein HSP 90-betaHomo sapiens (human)
histone methyltransferase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
unfolded protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
carbonyl reductase (NADPH) activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
alcohol dehydrogenase (NADP+) activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptorCarbonyl reductase [NADPH] 1Homo sapiens (human)
oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptorCarbonyl reductase [NADPH] 1Homo sapiens (human)
15-hydroxyprostaglandin-D dehydrogenase (NADP+) activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
15-hydroxyprostaglandin dehydrogenase (NADP+) activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
prostaglandin-E2 9-reductase activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
S-nitrosoglutathione reductase (NADPH) activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
protein kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
pyruvate dehydrogenase (acetyl-transferring) kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
protein binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
ATP binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
protein kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
pyruvate dehydrogenase (acetyl-transferring) kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
protein binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
ATP binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
protein homodimerization activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
protein kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
protein serine/threonine kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
pyruvate dehydrogenase (acetyl-transferring) kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
protein binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
ATP binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
protein kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
pyruvate dehydrogenase (acetyl-transferring) kinase activity[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
protein binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
ATP binding[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase Src Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (43)

Processvia Protein(s)Taxonomy
extracellular regionHeat shock protein HSP 90-alphaHomo sapiens (human)
nucleusHeat shock protein HSP 90-alphaHomo sapiens (human)
nucleoplasmHeat shock protein HSP 90-alphaHomo sapiens (human)
cytoplasmHeat shock protein HSP 90-alphaHomo sapiens (human)
mitochondrionHeat shock protein HSP 90-alphaHomo sapiens (human)
cytosolHeat shock protein HSP 90-alphaHomo sapiens (human)
plasma membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
cell surfaceHeat shock protein HSP 90-alphaHomo sapiens (human)
membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
basolateral plasma membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
apical plasma membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
brush border membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
secretory granule lumenHeat shock protein HSP 90-alphaHomo sapiens (human)
melanosomeHeat shock protein HSP 90-alphaHomo sapiens (human)
neuronal cell bodyHeat shock protein HSP 90-alphaHomo sapiens (human)
lysosomal lumenHeat shock protein HSP 90-alphaHomo sapiens (human)
dendritic growth coneHeat shock protein HSP 90-alphaHomo sapiens (human)
axonal growth coneHeat shock protein HSP 90-alphaHomo sapiens (human)
perinuclear region of cytoplasmHeat shock protein HSP 90-alphaHomo sapiens (human)
collagen-containing extracellular matrixHeat shock protein HSP 90-alphaHomo sapiens (human)
extracellular exosomeHeat shock protein HSP 90-alphaHomo sapiens (human)
endocytic vesicle lumenHeat shock protein HSP 90-alphaHomo sapiens (human)
sperm mitochondrial sheathHeat shock protein HSP 90-alphaHomo sapiens (human)
sperm plasma membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
ficolin-1-rich granule lumenHeat shock protein HSP 90-alphaHomo sapiens (human)
protein-containing complexHeat shock protein HSP 90-alphaHomo sapiens (human)
plasma membraneHeat shock protein HSP 90-alphaHomo sapiens (human)
neuronal cell bodyHeat shock protein HSP 90-alphaHomo sapiens (human)
perinuclear region of cytoplasmHeat shock protein HSP 90-alphaHomo sapiens (human)
myelin sheathHeat shock protein HSP 90-alphaHomo sapiens (human)
cytosolHeat shock protein HSP 90-alphaHomo sapiens (human)
nucleusHeat shock protein HSP 90-alphaHomo sapiens (human)
COP9 signalosomeHeat shock protein HSP 90-betaHomo sapiens (human)
protein folding chaperone complexHeat shock protein HSP 90-betaHomo sapiens (human)
extracellular regionHeat shock protein HSP 90-betaHomo sapiens (human)
nucleusHeat shock protein HSP 90-betaHomo sapiens (human)
nucleoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
cytoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
mitochondrionHeat shock protein HSP 90-betaHomo sapiens (human)
cytosolHeat shock protein HSP 90-betaHomo sapiens (human)
cell surfaceHeat shock protein HSP 90-betaHomo sapiens (human)
membraneHeat shock protein HSP 90-betaHomo sapiens (human)
secretory granule lumenHeat shock protein HSP 90-betaHomo sapiens (human)
melanosomeHeat shock protein HSP 90-betaHomo sapiens (human)
neuronal cell bodyHeat shock protein HSP 90-betaHomo sapiens (human)
dendritic growth coneHeat shock protein HSP 90-betaHomo sapiens (human)
axonal growth coneHeat shock protein HSP 90-betaHomo sapiens (human)
perinuclear region of cytoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
extracellular exosomeHeat shock protein HSP 90-betaHomo sapiens (human)
dynein axonemal particleHeat shock protein HSP 90-betaHomo sapiens (human)
ficolin-1-rich granule lumenHeat shock protein HSP 90-betaHomo sapiens (human)
protein-containing complexHeat shock protein HSP 90-betaHomo sapiens (human)
aryl hydrocarbon receptor complexHeat shock protein HSP 90-betaHomo sapiens (human)
HSP90-CDC37 chaperone complexHeat shock protein HSP 90-betaHomo sapiens (human)
perinuclear region of cytoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
plasma membraneHeat shock protein HSP 90-betaHomo sapiens (human)
cytosolHeat shock protein HSP 90-betaHomo sapiens (human)
cytosolCarbonyl reductase [NADPH] 1Homo sapiens (human)
extracellular exosomeCarbonyl reductase [NADPH] 1Homo sapiens (human)
extracellular vesicleCarbonyl reductase [NADPH] 1Homo sapiens (human)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
mitochondrial matrix[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
mitochondrion[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)
nucleoplasm[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
mitochondrion[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
mitochondrial matrix[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
cytosol[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
pyruvate dehydrogenase complex[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
mitochondrion[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrialHomo sapiens (human)
nucleolus[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
mitochondrion[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
mitochondrial matrix[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
mitochondrion[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialHomo sapiens (human)
mitochondrial matrix[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
mitochondrion[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrialHomo sapiens (human)
cytosolProto-oncogene tyrosine-protein kinase Src Rattus norvegicus (Norway rat)
plasma membraneProto-oncogene tyrosine-protein kinase Src Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (241)

Assay IDTitleYearJournalArticle
AID697050Competitive inhibition of rat liver ACLY using ATP as substrate by spectrophotometric analysis2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
The lipogenesis pathway as a cancer target.
AID1372065Inhibition of recombinant Caulobacter vibrioides cell cycle histidine kinase CckA deltaTM mutant DHp domain (70 to 691 residues) expressed in Escherichia coli in presence of varying levels of ATP measured every 60 secs for 2 hrs by PK/LDH enzyme coupled a2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID379397Inhibition of Hsp90 in rabbit reticulocyte lysate assessed as inhibition of heat-denatured firefly luciferase renaturation relative to geldanamycin2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID745765Displacement of [3H]-enkephalin from human delta opioid receptor transfected in CHOK1 cells at 10 uM after 60 mins relative to control2013Journal of natural products, 05-24, Volume: 76, Issue:5
Neocosmospora sp.-derived resorcylic acid lactones with in vitro binding affinity for human opioid and cannabinoid receptors.
AID395895Cytotoxicity against human MCF7 cells2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery and development of heat shock protein 90 inhibitors.
AID1604457Binding affinity to HSP90 (unknown origin) by isothermal titration calorimetry2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.
AID1224801Delta TM value showing the stabilisation of MST1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID278576Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1717620Antifungal activity against Mucor racemosus IF09255 by serial broth dilution method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1491575Cytotoxicity against mouse J774.A1 cells after 72 hrs by MTS assay2017ACS medicinal chemistry letters, Aug-10, Volume: 8, Issue:8
Synthesis and Activity of a New Series of Antileishmanial Agents.
AID1408671Non-competitive inhibition of rat liver ACLY using varying levels of citrate2018European journal of medicinal chemistry, Sep-05, Volume: 157ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
AID1372064Binding affinity to recombinant Caulobacter vibrioides cell cycle histidine kinase CckA delta 3 mutant DHp domain (190 to 562 residues) expressed in Escherichia coli assessed as change in metlting temperature at 30 uM after 2 mins by SYPRO orange dye base2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID347254Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADPH2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID347257Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADPH2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID347249Binding affinity to human recombinant PLK4 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID379404Inhibition of Hsp90 in human MCF7 cells assessed as upregulation of Hsp72 expression at 1 uM by chemiluminescence assay2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID87632The compound was tested for binding affinity against yeast Heat shock protein HSP 901999Journal of medicinal chemistry, Jan-28, Volume: 42, Issue:2
Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
AID1224762Delta TM value showing the stabilisation of CLK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224788Delta TM value showing the stabilisation of PIM3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID347259Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as NADPH oxidation using isatin as substrate2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID347243Binding affinity to human recombinant MAP3K5 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID403340Inhibition of COX22005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID355998Antiviral activity against HSV1 F infected in african green monkey Vero cells assessed as reduction of virus-induced cytopathic effect by cellular replication assay2003Journal of natural products, Jun, Volume: 66, Issue:6
Pochonins A-F, new antiviral and antiparasitic resorcylic acid lactones from Pochonia chlamydosporia var. catenulata.
AID1224759Delta TM value showing the stabilisation of CDKL1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224777Delta TM value showing the stabilisation of MST4(1) produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID506584Binding affinity to HSP90 in human NCI-H526 cells at 1 uM after 24 hrs by fluorescence polarization assay2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID1604455Antiproliferative activity against human MCF7 cells2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.
AID1224800Delta TM value showing the stabilisation of MST4 (2) produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID201165Concentration to inhibit growth of v-src-transformed cells (SR-3Y1 cells) after 72 h exposure2003Journal of medicinal chemistry, Jun-05, Volume: 46, Issue:12
Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicol.
AID312050Induction of heat shock in mouse 3T3-Y9/B12 reporter cells at 5 uM by heat shock induction assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Uncovering biosynthetic potential of plant-associated fungi: effect of culture conditions on metabolite production by Paraphaeosphaeria quadriseptata and Chaetomium chiversii.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1491574Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay2017ACS medicinal chemistry letters, Aug-10, Volume: 8, Issue:8
Synthesis and Activity of a New Series of Antileishmanial Agents.
AID247222Inhibitory concentration against cell proliferation of human HCT116 cell2005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design.
AID1170875Inhibition of PDHK3 (unknown origin)2014Journal of medicinal chemistry, Dec-11, Volume: 57, Issue:23
Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90.
AID745767Displacement of [3H]-U-69593 from human kappa opioid receptor transfected in CHOK1 cells at 10 uM after 60 mins relative to control2013Journal of natural products, 05-24, Volume: 76, Issue:5
Neocosmospora sp.-derived resorcylic acid lactones with in vitro binding affinity for human opioid and cannabinoid receptors.
AID347256Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADP+2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1224751Delta TM value showing the stabilisation of CAMK2A produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID257070Binding affinity to Hsp90 by fluorescent polarization assay2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Structure-based discovery of a new class of Hsp90 inhibitors.
AID1378625Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.
AID325658Inhibition of COX2 expression in LPS-stimulated human macrophages2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1441284Inhibition of HSP90 (unknown origin)2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase.
AID704332Inhibition of Saccharomyces cerevisiae Hsp902011Journal of medicinal chemistry, Feb-24, Volume: 54, Issue:4
ATP-binding site of bacterial enzymes as a target for antibacterial drug design.
AID356004Antiparasitic activity against Eimeria tenella Houghton infected in PCKC at 10 ppm treated 2 hrs postinfection by MMDA assay2003Journal of natural products, Jun, Volume: 66, Issue:6
Pochonins A-F, new antiviral and antiparasitic resorcylic acid lactones from Pochonia chlamydosporia var. catenulata.
AID1224764Delta TM value showing the stabilisation of CK1G1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1372052Antibacterial activity against Escherichia coli DC2 after 24 hrs by broth dilution method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID1224752Delta TM value showing the stabilisation of CAMK2B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1372053Antibacterial activity against Bacillus subtilis YB886 after 24 hrs by broth dilution method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID1224775Delta TM value showing the stabilisation of ERK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID356005Antiparasitic activity against Eimeria tenella Houghton infected in PCKC at 1 ppm treated 2 hrs postinfection by MMDA assay2003Journal of natural products, Jun, Volume: 66, Issue:6
Pochonins A-F, new antiviral and antiparasitic resorcylic acid lactones from Pochonia chlamydosporia var. catenulata.
AID408807Cytotoxicity against human SKBR3 cells after 24 hrs2008Bioorganic & medicinal chemistry, Jun-01, Volume: 16, Issue:11
Synthesis of Hsp90 inhibitor dimers as potential antitumor agents.
AID379403Inhibition of Hsp90 in human MCF7 cells assessed as upregulation of Hsp72 expression at 0.1 uM by chemiluminescence assay2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID314499Binding affinity at purified Hsp90 by DELFIA assay2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID1761924Binding affinity to recombinant human HSP90alpha by surface plasmon resonance analysis
AID1372035Inhibition of recombinant full length yeast N-terminal His-tagged Hsp90 expressed in Escherichia coli BL21 incubated overnight in presence of ATP by malachite green dye based assay2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID347235Binding affinity to human recombinant PIM1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID347242Binding affinity to human recombinant FES expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1073048Activation of PKC in human Jurkat cells assessed as NF-kappaB reporter gene activation after 24 hrs by FACS analysis2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells.
AID1224804Delta TM value showing the stabilisation of VRK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224758Delta TM value showing the stabilisation of CDK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID403072Antifungal activity against Candida albicans after 48 hrs by agar-based microtiter plate assay2005Journal of natural products, Aug, Volume: 68, Issue:8
Gymnoascolides A-C: aromatic butenolides from an Australian isolate of the soil ascomycete Gymnoascus reessii.
AID347241Binding affinity to human recombinant DYRK1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1224793Delta TM value showing the stabilisation of RSK2a produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224786Delta TM value showing the stabilisation of PIM1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1378627Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.
AID347248Binding affinity to human recombinant CSNK1G1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID763529Binding affinity to human Hsp90 by surface plasmon resonance analysis2013European journal of medicinal chemistry, Jul, Volume: 65Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors.
AID1625193Binding affinity to recombinant human HSP90 alpha by Surface plasmon resonance analysis2019Journal of natural products, 03-22, Volume: 82, Issue:3
Fusicoccane Diterpenes from Hypoestes forsskaolii as Heat Shock Protein 90 (Hsp90) Modulators.
AID1666493Binding affinity to N-terminal Hsp90 (unknown origin) assessed as change in melting temperature at protein to compound molar ratio of 1:5 by real-time PCR/PTS-dye based thermal shift assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
New modification strategy of matrine as Hsp90 inhibitors based on its specific L conformation for cancer treatment.
AID1224785Delta TM value showing the stabilisation of PDK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1625217Inhibition of HSP90 alpha (unknown origin) ATPase activity at 5 to 10 uM measured after 40 mins by malachite reagent based UV spectrophotometric analysis2019Journal of natural products, 03-22, Volume: 82, Issue:3
Fusicoccane Diterpenes from Hypoestes forsskaolii as Heat Shock Protein 90 (Hsp90) Modulators.
AID1905253Synergistic antifungal activity against fluconazole-resistant Candida albicans 904 assessed as inhibition of fungal growth in presence of fluconazole by checker board microdilution assay2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Species-Selective Targeting of Fungal Hsp90: Design, Synthesis, and Evaluation of Novel 4,5-Diarylisoxazole Derivatives for the Combination Treatment of Azole-Resistant Candidiasis.
AID269704Binding affinity to Hsp90 in MCF7 cell lysate2006Journal of medicinal chemistry, Aug-24, Volume: 49, Issue:17
7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors.
AID1717623Antifungal activity against Mucor mucedo IF06750 by serial broth dilution method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1408672Non-competitive inhibition of rat liver ACLY using citrate substrate and varying levels of ATP2018European journal of medicinal chemistry, Sep-05, Volume: 157ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
AID242027Inhibitory concentration against activity of Hsp90 was determined by fluorescence polarization (FP) assay(n=2)2005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design.
AID1224770Delta TM value showing the stabilisation of JAK1~B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224765Delta TM value showing the stabilisation of CK1G2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID604443Binding affinity to Hsp90alpha N-terminal ATPase domain by TR-FRET assay based competitive binding assay2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors.
AID697049Competitive inhibition of rat liver ACLY using citrate as substrate by spectrophotometric analysis2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
The lipogenesis pathway as a cancer target.
AID1224760Delta TM value showing the stabilisation of CHEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID506585Inhibition of HSP90-mediated proliferation of human NCI-H526 cells at 1 uM after 96 hrs by sulforhodamine B assay2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID1224750Delta TM value showing the stabilisation of CAMK1G produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1073050Reactivation of latent HIV1 NL4-3-Luc expression in human naive CD4+ T cells treated 7 days post-infection measured after 48 hrs by luminescence plate reader analysis relative to SAHA-treated control2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells.
AID1224757Delta TM value showing the stabilisation of CDK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID347255Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in absence of cofactor2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1378626Cytotoxicity against human A549 cells after 72 hrs by MTT assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.
AID1073051Reactivation of latent HIV1 NL4-3-Luc expression in human naive CD4+ T cells treated 7 days post-infection measured after 48 hrs by luminescence plate reader analysis2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells.
AID1372068Inhibition of recombinant Caulobacter vibrioides N-terminal His6-tagged DHp-catalytic domain DivJ (188 to 585 residues) expressed in Escherichia coli BL21 (DE3) preincubated for 10 mins followed by [gamma-32P]-ATP addition after 15 mins by phosphotransfer2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID347236Binding affinity to human recombinant PIM2 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID379398Displacement of geldanamycin from Hsp90 in human MCF7 cells lysate by SDS-PAGE2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID1224791Delta TM value showing the stabilisation of PRKACA produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID379400Inhibition of Hsp90 in human MCF7 cells assessed as depletion of cellular level of IGF1R at 1 uM by chemiluminescence assay2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID1224796Delta TM value showing the stabilisation of LOK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID379401Inhibition of Hsp90 in human MCF7 cells assessed as depletion of cellular level of ER at 0.1 uM by chemiluminescence assay2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID1224790Delta TM value showing the stabilisation of PLK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID278577Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
AID1170874Inhibition of PDHK1 (unknown origin)2014Journal of medicinal chemistry, Dec-11, Volume: 57, Issue:23
Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90.
AID347245Binding affinity to human recombinant SLK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID444540Antiproliferative activity against human SK-BR-3 cells2009Bioorganic & medicinal chemistry letters, Dec-15, Volume: 19, Issue:24
Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors.
AID347252Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in absence of cofactor2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID427104Inhibition of WNT5A mRNA expression in human dermal papilla cells after 24 hrs by quantigene assay2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Synthesis and structure-activity relationships of radicicol derivatives and WNT-5A expression inhibitory activity.
AID1224781Delta TM value showing the stabilisation of PAK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID356006Antiparasitic activity against Neospora caninum NC-1 infected in african green monkey Vero cells treated 2 hrs postinfection by MMDA assay2003Journal of natural products, Jun, Volume: 66, Issue:6
Pochonins A-F, new antiviral and antiparasitic resorcylic acid lactones from Pochonia chlamydosporia var. catenulata.
AID1224806Delta TM value showing the stabilisation of VRK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224772Delta TM value showing the stabilisation of MAP2K6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1372054Antibacterial activity against Caulobacter crescentus NA1000 after 24 hrs by broth dilution method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID1408673Inhibition of ACLY (unknown origin) in pancreatic beta cells assessed as reduction in 5 to 10 mM glucose-induced insulin secretion relative to control2018European journal of medicinal chemistry, Sep-05, Volume: 157ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
AID1905254Synergistic antifungal activity against fluconazole-resistant Candida albicans 632 assessed as inhibition of fungal growth in presence of fluconazole by checker board microdilution assay2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Species-Selective Targeting of Fungal Hsp90: Design, Synthesis, and Evaluation of Novel 4,5-Diarylisoxazole Derivatives for the Combination Treatment of Azole-Resistant Candidiasis.
AID356000Cytotoxicity against african green monkey Vero cells by crystal violet staining2003Journal of natural products, Jun, Volume: 66, Issue:6
Pochonins A-F, new antiviral and antiparasitic resorcylic acid lactones from Pochonia chlamydosporia var. catenulata.
AID1073052Reactivation of latent HIV1 NL4-3-Luc expression in human naive CD4+ T cells assessed as HIV-1 RNA expression treated 7 days post-infection by RT-qPCR analysis2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells.
AID1224798Delta TM value showing the stabilisation of DRAK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID347246Binding affinity to human recombinant LOK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1224773Delta TM value showing the stabilisation of ASK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224749Delta TM value showing the stabilisation of CAMK1D produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224756Delta TM value showing the stabilisation of CAMKK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID314504Growth inhibition of human DLD1 cells2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID95005Concentration to inhibit growth of normal rat K-ras-transformed cells (KNRK 5.2 cells) after 72 hr exposure2003Journal of medicinal chemistry, Jun-05, Volume: 46, Issue:12
Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicol.
AID379394Induction of heat shock response in mouse 3T3-Y9/B12 cells at 5 uM by fluorescence technique relative to geldanamycin2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID3433Concentration to inhibit growth of normal rat fibroblast cells (3Y1-B cells) after 72 h exposure2003Journal of medicinal chemistry, Jun-05, Volume: 46, Issue:12
Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicol.
AID314501Inhibition of Hsp90 in human KPL4 cells assessed as depletion of Raf-1 level after 40 hrs2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID1224783Delta TM value showing the stabilisation of PAK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID427105Cytotoxicity against human dermal papilla cells by Alamar blue assay2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Synthesis and structure-activity relationships of radicicol derivatives and WNT-5A expression inhibitory activity.
AID745763Displacement of [3H]-CP55940 from human recombinant CB1 receptor transfected in HEK293 cells at 10 uM after 90 mins relative to control2013Journal of natural products, 05-24, Volume: 76, Issue:5
Neocosmospora sp.-derived resorcylic acid lactones with in vitro binding affinity for human opioid and cannabinoid receptors.
AID395896Inhibition of Hsp902009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery and development of heat shock protein 90 inhibitors.
AID32535Inhibition of ATP-ase activity in human colon tumor cell line (HCT116)2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Adenine derived inhibitors of the molecular chaperone HSP90-SAR explained through multiple X-ray structures.
AID1224778Delta TM value showing the stabilisation of NEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1151278Growth inhibition of human A549 cells after 48 hrs by SRB assay2014Journal of natural products, May-23, Volume: 77, Issue:5
Aliphatic phenolic ethers from Trichobotrys effusa.
AID1378628Antifungal activity against Peronophythora litchii after 8 hrs by conidial germination assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.
AID1717619Inhibition of Mucor flavus IFO9560 chitin synthase incubated for 6 to 20 hrs by Lineweaver-Burk analysis2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID347244Binding affinity to human recombinant STK3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1224748Delta TM value showing the stabilisation of AMPKA2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID325657Inhibition of p60v-src kinase2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1905300Binding affinity to recombinant Candida albicans Hsp90 NBD expressed in Escherichia coli by SPR assay2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Species-Selective Targeting of Fungal Hsp90: Design, Synthesis, and Evaluation of Novel 4,5-Diarylisoxazole Derivatives for the Combination Treatment of Azole-Resistant Candidiasis.
AID1491573Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay2017ACS medicinal chemistry letters, Aug-10, Volume: 8, Issue:8
Synthesis and Activity of a New Series of Antileishmanial Agents.
AID314505Growth inhibition of human A549 cells2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID1717622Antifungal activity against Mucor mucedo IF07684 by serial broth dilution method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1224761Delta TM value showing the stabilisation of CLK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID499329Binding affinity to HSP90 after 4 hrs by surface plasmon resonance analysis2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Natural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors.
AID1224805Delta TM value showing the stabilisation of VRK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1378629Antifungal activity against Fusarium verticillioides after 8 hrs by conidial germination assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.
AID347250Binding affinity to human recombinant PAK6 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1224782Delta TM value showing the stabilisation of PAK5 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID347240Binding affinity to human recombinant MAPK11 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1905256Synergistic antifungal activity against fluconazole-resistant Candida albicans 103 assessed as inhibition of fungal growth in presence of fluconazole by checker board microdilution assay2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Species-Selective Targeting of Fungal Hsp90: Design, Synthesis, and Evaluation of Novel 4,5-Diarylisoxazole Derivatives for the Combination Treatment of Azole-Resistant Candidiasis.
AID379396Inhibition of Hsp90 in rabbit reticulocyte lysate assessed as inhibition of heat-denatured firefly luciferase renaturation at 10 uM relative to geldanamycin2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID356009Cytotoxicity against PCKC by crystal violet staining2003Journal of natural products, Jun, Volume: 66, Issue:6
Pochonins A-F, new antiviral and antiparasitic resorcylic acid lactones from Pochonia chlamydosporia var. catenulata.
AID1073049Inhibition of HSP90 (unknown origin)2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells.
AID1905252Synergistic antifungal activity against fluconazole-resistant Candida albicans 901 assessed as inhibition of fungal growth in presence of fluconazole by checker board microdilution assay2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Species-Selective Targeting of Fungal Hsp90: Design, Synthesis, and Evaluation of Novel 4,5-Diarylisoxazole Derivatives for the Combination Treatment of Azole-Resistant Candidiasis.
AID1905255Synergistic antifungal activity against fluconazole-resistant Candida albicans 100 assessed as inhibition of fungal growth in presence of fluconazole by checker board microdilution assay2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Species-Selective Targeting of Fungal Hsp90: Design, Synthesis, and Evaluation of Novel 4,5-Diarylisoxazole Derivatives for the Combination Treatment of Azole-Resistant Candidiasis.
AID347253Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADP+2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID379405Antiproliferative activity against human MCF7 cells by MTT assay2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID1224769Delta TM value showing the stabilisation of GSK3B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224807Delta TM value showing the stabilisation of YSK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1717621Antifungal activity against Mucor piriformis IF09416 by serial broth dilution method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1503774Cytotoxicity against human HL cells assessed as cell viability at 50 uM after 72 hrs by resazurin dye based fluorescence assay relative to control2017Journal of natural products, 10-27, Volume: 80, Issue:10
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
AID408806Cytotoxicity against human MCF7 cells after 24 hrs2008Bioorganic & medicinal chemistry, Jun-01, Volume: 16, Issue:11
Synthesis of Hsp90 inhibitor dimers as potential antitumor agents.
AID1224774Delta TM value showing the stabilisation of p38beta produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1372038Inhibition of recombinant Salmonella typhimurium N-terminal His6-SUMO-tagged DHp-catalytic domain PhoQ (257 to 487 residues) autophosphorylation expressed in Escherichia coli BL21 (DE3) preincubated for 10 mins followed by [gamma-32P]-ATP addition after 32017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID1441286Inhibition of PDHK (unknown origin)2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase.
AID314506Growth inhibition of human KPL4 cells2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID314503Growth inhibition of human HCT116 cells2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID1224799Delta TM value showing the stabilisation of NDR1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224803Delta TM value showing the stabilisation of PBK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224779Delta TM value showing the stabilisation of NEK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID347251Binding affinity to human recombinant Hsp90 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID347237Binding affinity to human recombinant PIM3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1441285Inhibition of SUMO-tagged PDHK1 (unknown origin) in presence of [gamma-32P]ATP after 30 mins by SDS-PAGE based phosphor imaging method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase.
AID745766Displacement of [3H]-DAMGO from human mu opioid receptor transfected in CHOK1 cells at 10 uM after 60 mins relative to control2013Journal of natural products, 05-24, Volume: 76, Issue:5
Neocosmospora sp.-derived resorcylic acid lactones with in vitro binding affinity for human opioid and cannabinoid receptors.
AID314502Induction of human K562 cells differentiation2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID379399Inhibition of Hsp90 in human MCF7 cells assessed as depletion of cellular level of IGF1R at 0.1 uM by chemiluminescence assay2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID745762Displacement of [3H]-CP55940 from human recombinant CB2 receptor transfected in HEK293 cells at 10 uM after 90 mins relative to control2013Journal of natural products, 05-24, Volume: 76, Issue:5
Neocosmospora sp.-derived resorcylic acid lactones with in vitro binding affinity for human opioid and cannabinoid receptors.
AID1224780Delta TM value showing the stabilisation of OSR1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID314500Inhibition of Hsp90 in human KPL4 cells assessed as depletion of ErbB2 level after 40 hrs2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
AID1224755Delta TM value showing the stabilisation of CAMK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224792Delta TM value showing the stabilisation of RIOK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1372039Binding affinity to recombinant Salmonella typhimurium 15N-labeled PhoQ catalytic domain (332 to 487 residues) expressed in Escherichia coli XA90 assessed as chemical shift perturbation by HSQC NMR analysis2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID1224771Delta TM value showing the stabilisation of MEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID347239Binding affinity to human recombinant MAPK6 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1224797Delta TM value showing the stabilisation of MPSK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1372049Hemolytic activity against sheep RBC at 0.5 mM after 30 mins relative to control2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID1224795Delta TM value showing the stabilisation of SLK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID87631The compound was tested for binding affinity against isolated N-domain of Heat shock protein HSP 901999Journal of medicinal chemistry, Jan-28, Volume: 42, Issue:2
Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
AID1224789Delta TM value showing the stabilisation of PLK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID403071Antifungal activity against Septoria nodorum after 48 hrs by agar-based microtiter plate assay2005Journal of natural products, Aug, Volume: 68, Issue:8
Gymnoascolides A-C: aromatic butenolides from an Australian isolate of the soil ascomycete Gymnoascus reessii.
AID1717626Antifungal activity against Mucor javanicus IFO4569 by serial broth dilution method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID311881Inhibition of Hsp902007Journal of natural products, Dec, Volume: 70, Issue:12
Derrubone, an inhibitor of the Hsp90 protein folding machinery.
AID379395Cytotoxicity against in mouse 3T3-Y9/B12 cells at 10 uM2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID395890Binding affinity to N-terminal ATP/ADP-binding domain of yeast Hsp902009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery and development of heat shock protein 90 inhibitors.
AID1717625Antifungal activity against Mucor hiemalis IFO9400 by serial broth dilution method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID379402Inhibition of Hsp90 in human MCF7 cells assessed as depletion of cellular level of ER at 1 uM by chemiluminescence assay2006Journal of natural products, Feb, Volume: 69, Issue:2
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
AID1224787Delta TM value showing the stabilisation of PIM2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID228843Inhibition of v-Src tyrosine kinase autophosphorylation in SR3Y1 cells after 15 hr exposure2003Journal of medicinal chemistry, Jun-05, Volume: 46, Issue:12
Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicol.
AID1224766Delta TM value showing the stabilisation of CK1G3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224767Delta TM value showing the stabilisation of DAPK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224776Delta TM value showing the stabilisation of ERK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID640831Inhibition of SOD1 G93A mutant protein aggregation-mediated cytotoxicity in rat PC12 cells expressing yellow fluorescent protein assessed as increase in cell viability2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cells.
AID1224754Delta TM value showing the stabilisation of CAMK2G produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1372042Inhibition of recombinant Caulobacter vibrioides N-terminal His6-tagged DHp-catalytic domain DivJ (188 to 585 residues) autophosphorylation expressed in Escherichia coli BL21(DE3) at 500 uM preincubated for 10 mins followed by [gamma-32P]-ATP addition aft2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID444539Antiproliferative activity against human MCF7 cells2009Bioorganic & medicinal chemistry letters, Dec-15, Volume: 19, Issue:24
Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors.
AID1224753Delta TM value showing the stabilisation of CAMK2D produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID604444Inhibition of Hsp90alpha ATPase activity by malachite green ATP-ase assay2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors.
AID704334Inhibition of Saccharomyces cerevisiae sensor kinase Sln12011Journal of medicinal chemistry, Feb-24, Volume: 54, Issue:4
ATP-binding site of bacterial enzymes as a target for antibacterial drug design.
AID242325Inhibitory concentration against ATPase activity of Hsp90 of Saccharomyces cerevisiae was determined by ATPase activity assay2005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design.
AID146216Concentration to inhibit growth of normal rat kidney epithelial cells (NRK cells) after 72 hr exposure2003Journal of medicinal chemistry, Jun-05, Volume: 46, Issue:12
Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicol.
AID1224802Delta TM value showing the stabilisation of TNIK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1717624Antifungal activity against Mucor mucedo IF05776 by serial broth dilution method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID347238Binding affinity to human recombinant GAK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID257069Inhibition of cell proliferation in HCT116 human colon cancer cell line2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Structure-based discovery of a new class of Hsp90 inhibitors.
AID1224768Delta TM value showing the stabilisation of DMPK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID347247Binding affinity to human recombinant MAP2K6 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID730648Binding affinity to recombinant Hsp90 alpha (unknown origin) by surface plasmon resonance2013Journal of medicinal chemistry, Feb-28, Volume: 56, Issue:4
A chemical-biological study reveals C9-type iridoids as novel heat shock protein 90 (Hsp90) inhibitors.
AID1490052Binding affinity to dog N-terminal GST-tagged GRP94 N41 deletion mutant (69 to 337 residues) expressed in Escherichia coli BL21star (DE3) at 298 K by ITC assay2018Journal of medicinal chemistry, 04-12, Volume: 61, Issue:7
Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.
AID1372041Inhibition of recombinant Salmonella typhimurium N-terminal His6-SUMO-tagged DHp-catalytic domain PhoQ (257 to 487 residues) autophosphorylation expressed in Escherichia coli BL21(DE3) at 500 uM preincubated for 10 mins followed by [gamma-32P]-ATP additio2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
AID1188659Drug metabolism in human liver microsomes2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors.
AID1224794Delta TM value showing the stabilisation of RSK2b produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224763Delta TM value showing the stabilisation of CLK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1181931Displacement of FITC-geldanamycin from human HSP90 at 0.001 to 10000 nM by fluorescence polarization assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.
AID1717627Antifungal activity against Mucor flavus IFO9560 by serial broth dilution method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1224784Delta TM value showing the stabilisation of PCTK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID704333Inhibition of Salmonella typhimurium sensor kinase PhoQ2011Journal of medicinal chemistry, Feb-24, Volume: 54, Issue:4
ATP-binding site of bacterial enzymes as a target for antibacterial drug design.
AID1905257Synergistic antifungal activity against fluconazole-resistant Candida albicans 311 assessed as inhibition of fungal growth in presence of fluconazole by checker board microdilution assay2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Species-Selective Targeting of Fungal Hsp90: Design, Synthesis, and Evaluation of Novel 4,5-Diarylisoxazole Derivatives for the Combination Treatment of Azole-Resistant Candidiasis.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2009ACS chemical biology, Apr-17, Volume: 4, Issue:4
Structural basis of the radicicol resistance displayed by a fungal hsp90.
AID1797382Colorimetric Determination of ATPase Activity from Article 10.1016/j.chembiol.2004.03.033: \\Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.\\2004Chemistry & biology, Jun, Volume: 11, Issue:6
Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.
AID1797381Fluorescence Polarization (FP) Assay from Article 10.1021/jm050355z: \\Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design.\\2005Journal of medicinal chemistry, Jun-30, Volume: 48, Issue:13
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design.
AID1799518Malachite Green Assay from Article 10.1016/j.chembiol.2006.09.015: \\Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol.\\2006Chemistry & biology, Nov, Volume: 13, Issue:11
Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol.
AID1799517FP Assay from Article 10.1016/j.chembiol.2006.09.015: \\Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol.\\2006Chemistry & biology, Nov, Volume: 13, Issue:11
Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol.
AID1797384Fluorescence Polarization (FP) Assay from Article 10.1016/j.bmcl.2005.08.092: \\Structure-based discovery of a new class of Hsp90 inhibitors.\\2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Structure-based discovery of a new class of Hsp90 inhibitors.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2007Structure (London, England : 1993), Aug, Volume: 15, Issue:8
Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2012Journal of biomolecular screening, Aug, Volume: 17, Issue:7
Fragment screening using capillary electrophoresis (CEfrag) for hit identification of heat shock protein 90 ATPase inhibitors.
AID1811Experimentally measured binding affinity data derived from PDB1999Journal of medicinal chemistry, Jan-28, Volume: 42, Issue:2
Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB1999Journal of medicinal chemistry, Jan-28, Volume: 42, Issue:2
Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
AID1802790PDK Inhibition Assay from Article 10.1074/jbc.M113.533885: \\Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.\\2014The Journal of biological chemistry, Feb-14, Volume: 289, Issue:7
Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.
AID1802791Isothermal Titration Calorimetry (ITC) from Article 10.1074/jbc.M113.533885: \\Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.\\2014The Journal of biological chemistry, Feb-14, Volume: 289, Issue:7
Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2008Structure (London, England : 1993), Mar, Volume: 16, Issue:3
Crystal structure of an intact type II DNA topoisomerase: insights into DNA transfer mechanisms.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2008Journal of molecular biology, May-23, Volume: 379, Issue:1
The Hsp90 inhibitor radicicol interacts with the ATP-binding pocket of bacterial sensor kinase PhoQ.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (339)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.29)18.7374
1990's37 (10.91)18.2507
2000's182 (53.69)29.6817
2010's102 (30.09)24.3611
2020's17 (5.01)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews26 (7.62%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other315 (92.38%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]